Showing results (881-890 of 981) with videos related to

Sort By:
Pageof 99
American Journal on Intellectual and Developmental Disabilities|January 3, 2022
Anxiety in Angelman SyndromeStacey C Grebe, Danica L Limon, Morgan M McNeel, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|September 30, 2025
Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO StudyDavid S Mathai, Jill O Robinson, Kevin Wagner, et al.
Journal of Clinical Psychology in Medical Settings|January 28, 2024
Psychosocial Outcomes of Pain and Pain Management in Adults with Osteogenesis Imperfecta: A Qualitative StudyWhitney S Shepherd, Andrew D Wiese, Hannah E Cho, et al.
Disability and Health Journal|June 23, 2026
Sociodemographic and clinical predictors of resilience in individuals with osteogenesis imperfectaMadeline Hawkins, Emily Strouphauer, Ryan McCarty, et al.
Frontiers in Psychology|January 2, 2023
FAST CBT for pediatric OCD: A multiple-baseline controlled pilot trial of parent training in exposure and response prevention delivered via telehealthLara J Farrell, Natalja A Nabinger de Diaz, Sharna Mathieu, et al.
Nature Communications|December 18, 2019
The upper-airway microbiota and loss of asthma control among asthmatic childrenYanjiao Zhou, Daniel Jackson, Leonard B Bacharier, et al.
Journal of Mood and Anxiety Disorders|July 14, 2025
Clinical characteristics and longitudinal associations with obsessive-compulsive disorder in youth exposed to traumaCaitlin M Pinciotti, Paul J Rathouz, Andrew G Guzick, et al.
Disability and Rehabilitation|June 6, 2024
Resilience and coping: a qualitative analysis of cognitive and behavioral factors in adults with osteogenesis ImperfectaHannah E Cho, Whitney S Shepherd, Gianna M Colombo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 2, 2021
CTOTC-08: A multicenter randomized controlled trial of rituximab induction to reduce antibody development and improve outcomes in pediatric lung transplant recipientsStuart C Sweet, Brian Armstrong, Joshua Blatter, et al.
Pageof 99